Roche, Artery in APOA1 deal

Artery Therapeutics Inc. (Danville, Calif.) partnered with Roche (SIX:ROG; OTCQX:RHHBY) to co-develop Artery's apolipoprotein A-1 (APOA1) peptide mimetics. The deal includes Artery's lead, AT5261, whi...